At least that’s what Joel Sherman of the New York Post is reporting:
… executives from three teams that had interest in Damon expressed concerns a fixation with 3,000 has diminished an attribute that greatly contributed to the perception of Damon as a winning player: patient, tough at-bats. And statistics appear to confirm the criticism.
Sherman notes — via citation to FanGraphs, which is nice to see — that Damon has been swinging at more pitches out of the strike zone and that pitchers are throwing him fewer pitches in the zone as a result.
Frankly, if Damon can’t draw a lot of walks, he’s not very useful to anyone.
Ken Rosenthal of The Athletic confirms a report from journalist Américo Celado that White Sox catcher Welington Castillo will be suspended 80 games for violating baseball’s Joint Drug Agreement. Castillo was believed to have used a steroid, but according to Rosenthal, the substance was not a steroid. More details should come on Thursday.
Castillo, 31, entered Wednesday’s action batting .270/.314/.477 with six home runs and 15 RBI in 118 plate appearances. He has gotten the bulk of the work behind the plate, backed up by Omar Narváez.
Castillo’s absence will likely prompt the White Sox to call up Kevan Smith from Triple-A Charlotte. Smith battled an ankle injury in March and April, so he got a late start to the season. In 102 PA at Triple-A, he has hit .283/.343/.457.